Company profile for Chia Tai Tianqing Pharmaceutical Group

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At present, CTTQ manufactures over 50 prescription medicines in 5 core therapeutic areas, including liver diseases, oncology, respiratory diseases, antibiotics, and diabetes. CTTQ has 2 R&D centers and institutes with a total of over 1800 employees and invests 10%-12% of our annual sales revenue in R&D every year. The company currently has 3 manufacturing plants focusing on FDF and API production, 2 R&D centers, 1 overseas bra...
At present, CTTQ manufactures over 50 prescription medicines in 5 core therapeutic areas, including liver diseases, oncology, respiratory diseases, antibiotics, and diabetes. CTTQ has 2 R&D centers and institutes with a total of over 1800 employees and invests 10%-12% of our annual sales revenue in R&D every year. The company currently has 3 manufacturing plants focusing on FDF and API production, 2 R&D centers, 1 overseas branch (CTTQ EU) in Barcelona, Spain, 1 business development office in San Diego, USA, and 4 joint labs (in Shanghai and Chengdu).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
No. 369 South Yuzhou Rd, Haizhou District, Lianyungang, Jiangsu Province
Telephone
Telephone
+86 51886095133
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217365

FDA
13 Nov 2025

https://www.businesswire.com/news/home/20250828998660/en/Novotech-Supports-Groundbreaking-Approval-of-Anlotinib-Combination-Therapy-for-Advanced-Soft-Tissue-Sarcoma

BUSINESSWIRE
28 Aug 2025

https://www.globenewswire.com/news-release/2025/07/07/3111282/0/en/Inventiva-receives-10-million-milestone-payment-from-CTTQ.html

GLOBENEWSWIRE
07 Jul 2025

https://www.businesswire.com/news/home/20250604359716/en/Biocytogen-and-Nanjing-Chia-Tai-Tianqing-Announce-IND-Approval-in-China-for-Co-Developed-Anti-IGF-1R-Antibody-NTB003-BCG009

BUSINESSWIRE
04 Jun 2025

https://www.biospectrumasia.com/news/25/25314/cu-medicine-and-cttq-collaborate-to-strengthen-pharma-innovations-in-hong-kong.html

BIOSPECTRUM
10 Dec 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-braces-generic-challenge-ozempic-wegovy-china-2024-06-05/

Andrew Silver REUTERS
06 Jun 2024

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Chia Tai Tianqing Pharmaceutical Group and get a quotation

Chia Tai Tianqing Pharmaceutical Group is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Foscarnet Sodium bulk offered by Chia Tai Tianqing Pharmaceutical Group

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty